Invention Application
- Patent Title: A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID
-
Application No.: US17396464Application Date: 2021-08-06
-
Publication No.: US20220169674A1Publication Date: 2022-06-02
- Inventor: Paul Steven Watson , Bret Berner , John Gregory Reid , Jian Wang , James J. Doherty , Stephen Jay Kanes
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: C07J43/00
- IPC: C07J43/00 ; C07D231/14 ; A61P37/00 ; A61P25/22 ; A61P25/18 ; A61P25/24 ; A61P25/00 ; A61P25/08
Abstract:
This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.
Public/Granted literature
- US11884696B2 Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid Public/Granted day:2024-01-30
Information query
